Patient characteristics
| Characteristic | Chemotherapy+Vitamins (arm A) N=40 (48%) | Chemotherapy (arm B) N=43 (52%) |
|---|---|---|
| Age at diagnosis (years) | ||
| Median (IQR) | 61 (12) | 60 (14) |
| Sex | ||
| Male | 29 (72.5%) | 24 (56%) |
| Female | 11 (27.5%) | 19 (44%) |
| Diagnosis | ||
| NSCLC | 34 (85%) | 39 (91%) |
| SCLC | 3 (7.5%) | 3 (7%) |
| Mesothelioma | 3 (7.5%) | 1 (2%) |
| Performance status at diagnosis | ||
| 0 | 3 (7.5%) | 2 (5%) |
| 1 | 32 (80%) | 36 (84%) |
| 2 | 5 (12.5%) | 5 (11%) |
| First-line treatment | 35 (87.5%) | 39 (91%) |
| Second-line treatment | 5 (12.5%) | 4 (9%) |
NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer.